{"component": "definition", "props": {"groups": [{"samples": [{"hash": "75QLNHsVHqY", "uri": "https://www.cbhs.com.au/docs/librariesprovider2/legal/health-benefit-fund-rules.pdf?sfvrsn=776e5f5b_28", "label": "www.cbhs.com.au", "score": 17.8275299072, "published": false}, {"hash": "aoWrqSeQyQ", "uri": "https://www.cbhs.com.au/docs/librariesprovider2/legal/health-benefit-fund-rules.pdf?sfvrsn=776e5f5b_5", "label": "www.cbhs.com.au", "score": 16.9531936646, "published": false}, {"hash": "9j1RY6wh8WO", "uri": "https://www.cbhscorporatehealth.com.au/docs/librariesprovider3/documents/fund-rules.pdf?sfvrsn=e84ec130_12", "label": "www.cbhscorporatehealth.com.au", "score": 12.0773439407, "published": false}], "snippet_links": [], "snippet": "means a substance which:", "size": 13, "hash": "af2f7e401e94e0077aab68947a1f6461", "id": 1}, {"samples": [{"hash": "ljkmCFvMBTk", "uri": "https://www.waitematadhb.govt.nz/assets/Documents/consumer-council/Consumer-Council-Agenda-Nov2020-web.pdf", "label": "www.waitematadhb.govt.nz", "score": 10.4401092529, "published": false}, {"hash": "1DTdaVX69Zs", "uri": "https://pharmac.govt.nz/assets/DRAFT-Specialist-Advisory-Committee-Terms-of-Reference-2020.pdf", "label": "pharmac.govt.nz", "score": 8.4757013321, "published": false}, {"hash": "k5GY9STycdC", "uri": "https://pharmac.govt.nz/assets/DRAFT-PTAC-Terms-of-Reference-2020.pdf", "label": "pharmac.govt.nz", "score": 8.4757013321, "published": false}], "snippet_links": [{"key": "nzphd-act", "type": "definition", "offset": [25, 34]}, {"key": "medical-device", "type": "clause", "offset": [60, 74]}, {"key": "related-product", "type": "definition", "offset": [79, 94]}], "snippet": "means, as defined in the NZPHD Act, a medicine, therapeutic medical device, or related product or related thing.", "size": 5, "hash": "8b4e694959e1e6807706500343b626e6", "id": 2}, {"samples": [{"hash": "b49CLqCwGDq", "uri": "/contracts/b49CLqCwGDq#pharmaceuticals", "label": "Joint Venture and Operating Agreement", "score": 31.3408622742, "published": true}, {"hash": "i7LATf5W1CV", "uri": "/contracts/i7LATf5W1CV#pharmaceuticals", "label": "License Agreement (Solazyme Inc)", "score": 22.3607120514, "published": true}, {"hash": "fwFbO9JX8TO", "uri": "/contracts/fwFbO9JX8TO#pharmaceuticals", "label": "Joint Venture and Operating Agreement (Solazyme Inc)", "score": 22.2785758972, "published": true}], "snippet_links": [{"key": "treatment-of", "type": "definition", "offset": [105, 117]}, {"key": "each-case", "type": "definition", "offset": [175, 184]}, {"key": "governmental-regulatory-authority", "type": "definition", "offset": [241, 274]}, {"key": "benefits-provided", "type": "definition", "offset": [377, 394]}, {"key": "functional-foods", "type": "definition", "offset": [398, 414]}, {"key": "dietary-supplements", "type": "definition", "offset": [419, 438]}], "snippet": "means products containing one or more active components intended for the diagnosis, cure, mitigation, or treatment of a specific disease or condition in humans or animals, in each case, that have been specifically approved for such use by a governmental regulatory authority. Pharmaceuticals are thus used for a specific medicinal benefit that is distinct from the nutritional benefits provided by Functional Foods and Dietary Supplements.", "size": 4, "hash": "c321e5eccc2a578732489423ac02becd", "id": 3}, {"samples": [{"hash": "65s2OXyk0Cw", "uri": "https://www.pharmac.govt.nz/assets/Pharmac-Board-Governance-Manual.pdf", "label": "www.pharmac.govt.nz", "score": 16.1174983978, "published": false}, {"hash": "cQtf8OUJHVh", "uri": "https://pharmac.govt.nz/assets/2024-Pharmac-Board-Governance-Manual.pdf", "label": "pharmac.govt.nz", "score": 8.1553726196, "published": false}, {"hash": "lIUV96hGTLD", "uri": "https://pharmac.govt.nz/assets/2022-PHARMAC-Board-Governance-Manual.pdf", "label": "pharmac.govt.nz", "score": 7.4668035507, "published": false}], "snippet_links": [{"key": "medical-devices", "type": "clause", "offset": [59, 74]}, {"key": "related-to", "type": "definition", "offset": [98, 108]}], "snippet": "means substances or things that are medicines, therapeutic medical devices, or products or things related to pharmaceuticals.", "size": 4, "hash": "8a80b3716436424a19d487b38fe49a82", "id": 4}, {"samples": [{"hash": "4fOcPHmL0kB", "uri": "https://www.oil.bm/wp-content/uploads/Premium-Indication-Request-Form-PIRF-February-2022.pdf", "label": "www.oil.bm", "score": 11.0451745987, "published": false}, {"hash": "em9V5GDztvz", "uri": "https://www.everen.bm/wp-content/uploads/Premium-Indication-Request-Form-PIRF-December-2020.pdf", "label": "www.everen.bm", "score": 10.5249824524, "published": false}, {"hash": "dyik7uB6bxP", "uri": "https://www.oil.bm/wp-content/uploads/Premium-Indication-Request-Form-PIRF-March-2019.pdf", "label": "www.oil.bm", "score": 9.6639289856, "published": false}], "snippet_links": [{"key": "unmodified-gross-assets", "type": "definition", "offset": [31, 54]}, {"key": "business-operations", "type": "definition", "offset": [71, 90]}, {"key": "engaged-in", "type": "definition", "offset": [91, 101]}, {"key": "manufacturing-and-marketing", "type": "clause", "offset": [130, 157]}, {"key": "prescription-and-over", "type": "clause", "offset": [171, 192]}, {"key": "related-products", "type": "clause", "offset": [228, 244]}], "snippet": "means the Sector for reporting Unmodified Gross Assets of companies or business operations engaged in the discovery, development, manufacturing and marketing of vaccines, prescription and over-the-counter medicines, and health- related products for humans and animals.", "size": 4, "hash": "df962c42ca2cda57a5391198d3749b09", "id": 5}, {"samples": [{"hash": "27U7XHxhARo", "uri": "https://www.oil.bm/wp-content/uploads/Premium-Indication-Request-Form-PIRF-May-2022-1.pdf", "label": "www.oil.bm", "score": 11.188911438, "published": false}, {"hash": "2NDMqLRsUJB", "uri": "https://www.everen.bm/wp-content/uploads/Premium-Indication-Request-Form-PIRF-May-2022.pdf", "label": "www.everen.bm", "score": 11.1875429153, "published": false}], "snippet_links": [{"key": "unmodified-gross-assets", "type": "definition", "offset": [31, 54]}, {"key": "business-operations", "type": "definition", "offset": [71, 90]}, {"key": "engaged-in", "type": "definition", "offset": [91, 101]}, {"key": "prescription-and-over", "type": "clause", "offset": [175, 196]}, {"key": "related-products", "type": "clause", "offset": [235, 251]}], "snippet": "means the Sector for reporting Unmodified Gross Assets of companies or business operations engaged in the discovery, development, manufacturing, and/or marketing of vaccines, prescription and over-the-counter medicines, and/or health- related products for humans and/or animals.", "size": 4, "hash": "ab4593939cf8f64199e37efcf72400ee", "id": 6}, {"samples": [{"hash": "1jo0eERCT6S", "uri": "https://www.thunderbay.ca/en/city-hall/resources/Documents/Committees-and-Boards/Agenda-June-24-2019-CC.pdf", "label": "www.thunderbay.ca", "score": 9.7282686234, "published": false}, {"hash": "3pUqdxWXhmA", "uri": "https://www.thunderbay.ca/en/city-hall/resources/Sewer-Use-By-law_2019.pdf", "label": "www.thunderbay.ca", "score": 7.751540184, "published": false}, {"hash": "fn6VjlK6iFx", "uri": "https://www.thunderbay.ca/en/city-hall/resources/Documents/Committees-and-Boards/AddInfo-E-Package-Friday-May-31st.pdf", "label": "www.thunderbay.ca", "score": 7.7049965858, "published": false}], "snippet_links": [{"key": "drug-or-medicine", "type": "definition", "offset": [8, 24]}, {"key": "medical-treatment", "type": "definition", "offset": [81, 98]}], "snippet": "means a drug or medicine that is prepared or dispensed in pharmacies and used in medical treatment;", "size": 3, "hash": "ac27ee0d7f30ff4e846ecba2ed9ace63", "id": 7}, {"samples": [{"hash": "g4pXdJlg9dH", "uri": "http://register.dls.virginia.gov/vol27/iss12/v27i12.htm", "label": "Joint Venture", "score": 14.1704311371, "published": false}, {"hash": "9uSFjZdomkF", "uri": "http://register.dls.virginia.gov/vol18/iss12/v18i12.pdf", "label": "register.dls.virginia.gov", "score": 10.1704311371, "published": false}, {"hash": "g7T2uCdFHfJ", "uri": "http://register.dls.virginia.gov/vol27/iss12/v27i12.pdf", "label": "register.dls.virginia.gov", "score": 5.5516767502, "published": false}], "snippet_links": [{"key": "nonprescription-drugs", "type": "definition", "offset": [23, 44]}], "snippet": "means prescription and nonprescription drugs.", "size": 3, "hash": "0cb7188706563dd26f31371259613ba5", "id": 8}, {"samples": [{"hash": "4qR2g1zBbMo", "uri": "/contracts/4qR2g1zBbMo#pharmaceuticals", "label": "License Agreement (Roka BioScience, Inc.)", "score": 25.5119781494, "published": true}, {"hash": "7LQQe1haka7", "uri": "/contracts/7LQQe1haka7#pharmaceuticals", "label": "License Agreement (Roka BioScience, Inc.)", "score": 25.4626960754, "published": true}, {"hash": "2y6M0BtJsf8", "uri": "/contracts/2y6M0BtJsf8#pharmaceuticals", "label": "License Agreement (Roka BioScience, Inc.)", "score": 25.1971244812, "published": true}], "snippet_links": [{"key": "products-or-services", "type": "definition", "offset": [6, 26]}, {"key": "testing-samples", "type": "clause", "offset": [38, 53]}, {"key": "for-the-purpose-of", "type": "definition", "offset": [77, 95]}, {"key": "clinical-diagnostics", "type": "definition", "offset": [96, 116]}, {"key": "primary-purpose", "type": "definition", "offset": [135, 150]}, {"key": "medical-conditions", "type": "clause", "offset": [225, 243]}, {"key": "therapeutic-products", "type": "clause", "offset": [260, 280]}, {"key": "medical-devices", "type": "clause", "offset": [395, 410]}, {"key": "in-vitro-diagnostic", "type": "definition", "offset": [422, 441]}, {"key": "ophthalmic-products", "type": "definition", "offset": [468, 487]}, {"key": "nutraceutical-products", "type": "definition", "offset": [494, 516]}, {"key": "cell-therapy", "type": "definition", "offset": [537, 549]}], "snippet": "means products or services (excluding testing samples from humans or animals for the purpose of clinical diagnostics) intended for the primary purpose of preventing or treating human or veterinary diseases, disease states or medical conditions, including: (i) therapeutic products, including pharmaceuticals, parenterals, and biopharmaceuticals; (ii) vaccines; (iii) radio pharmaceuticals; (iv) medical devices (excluding in vitro diagnostic devices or products); (v) ophthalmic products; (vi) nutraceutical products; and (vii) gene and cell therapy products.", "size": 3, "hash": "b67ced8a8ce6fc9a74e5a9f7f9d685bc", "id": 9}, {"samples": [{"hash": "cr8kFEXHUnL", "uri": "https://pharma-dept.gov.in/sites/default/files/Revised%20guidelines%20pdf%20SPI%20dated%2014.03.2024.pdf", "label": "pharma-dept.gov.in", "score": 17.0393695831, "published": false}, {"hash": "chJzu3O1811", "uri": "https://pharma-dept.gov.in/sites/default/files/Revised%20guidelines%20SPI%20dated%2014.03.2024.pdf", "label": "pharma-dept.gov.in", "score": 17.0331039429, "published": false}, {"hash": "jEuAlyjK8PV", "uri": "https://pharma-dept.gov.in/sites/default/files/Approved%20Guidelines%20of%20scheme%20Strengthening%20of%20Pharmaceutical%20Industries%20(SPI)%2011032022.pdf", "label": "pharma-dept.gov.in", "score": 15.0910301208, "published": false}], "snippet_links": [{"key": "treatment-of", "type": "definition", "offset": [65, 77]}, {"key": "section-3", "type": "clause", "offset": [177, 186]}, {"key": "drugs-and-cosmetics-act", "type": "definition", "offset": [194, 217]}], "snippet": "means medicines and substances intended to be used for or in the treatment of diseases of human beings or animals, and includes such components as defined in sub section (b) of Section 3 of the Drugs and Cosmetics Act, 1940.", "size": 3, "hash": "0273f25cac557d5eb23e5d8697f8e594", "id": 10}], "next_curs": "ClwSVmoVc35sYXdpbnNpZGVyY29udHJhY3RzcjgLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIYcGhhcm1hY2V1dGljYWxzIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"title": "Pharmaceuticals", "snippet": "means a substance which:", "size": 81, "id": "pharmaceuticals", "examples": ["As far as the Renal <strong>Pharmaceuticals</strong> are included in the Pharmaceutical categories in Exhibit G, the license granted under this Section 4.2(ii)a) is granted exclusively.", "Notices to Kiniksa must include a copy to Kiniksa <strong>Pharmaceuticals</strong> Corp., \u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587, \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587, \u2587\u2587 \u2587\u2587\u2587\u2587\u2587, \u2587\u2587\u2587, Attention: Legal Department."], "related": [["pharmaceutical-care", "Pharmaceutical care", "Pharmaceutical care"], ["radiopharmaceutical", "Radiopharmaceutical", "Radiopharmaceutical"], ["information-technologies", "Information Technologies", "Information Technologies"], ["therapeutic-care", "Therapeutic care", "Therapeutic care"], ["solutions", "Solutions", "Solutions"]], "related_snippets": [], "updated": "2026-02-26T05:44:22+00:00"}, "json": true, "cursor": ""}}